Who Owns Gene Editing? Patents in the Time of CRISPR
Biochemist, Vol. 38, p. 26 (2016)
4 Pages Posted: 16 Feb 2017
Date Written: April 5, 2016
New gene-editing technologies, like CRISPR, promise revolutionary advances in biology and medicine. However, several patent disputes in the USA and UK may have complicated who can use CRISPR. What does this mean for the future of gene editing?
Keywords: intellectual property, patent, biotech, biotechnology, crispr, genetics
JEL Classification: K00, K23, K41, O3, O34, D23, K11
Suggested Citation: Suggested Citation